Today on the Medscape Medical Minute: Pfizer's CEO calls the Biden administration's Medicare drug pricing plan "negotiation with a gun to your head"; new safety warnings are coming to prevent abuse of ADHD drugs; and the first-ever medication for Alzheimer's agitation is approved.